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Abstract 
Introduction: Bartonella bacilliformis is the etiological agent of Carrion’s disease, which is a neglected disease linked to people in low-
socioeconomic populations in Andean valleys. An outbreak of B. bacilliformis was reported in a rural area of the Peruvian Amazon region. 
The aim of this study was to characterize this outbreak using molecular techniques. 
Methodology: Fifty-three blood samples from patients diagnosed with Carrion’s disease were analyzed by molecular tools, using both a 
Bartonella-specific polymerase chain reaction (PCR) and an universal PCR, both based on 16S rRNA gene amplification. Additional water 
samples from the area were also analyzed. 
Results: Unexpectedly, the samples were positive only when the universal PCR was used. Although environmental contamination cannot be 
ruled out, the results showed that Sphingomonas faeni was the possible causative agent of this outbreak, and that water was the most feasible 
infection source. 
Conclusions: Diagnosis by clinical criteria or microscopy may lead to misdiagnosis. There is a need to include molecular tools in the routine 
diagnosis of febrile syndromes, including Carrion’s disease. 
 
Key words: Bartonella spp.; Sphingomonas; diagnosis; outbreak; Peru. 
 
J Infect Dev Ctries 2015; 9(5):524-529. doi:10.3855/jidc.6235 
 
(Received 09 November 2014 – Accepted 10 February 2015) 
 
Copyright © 2015 Cornejo et al. This is an open-access article distributed under the Creative Commons Attribution License, which permits unrestricted use, 
distribution, and reproduction in any medium, provided the original work is properly cited. 
 
Introduction 
In northern Peru, the presence of different 
etiologic causes of febrile syndromes, including 
dengue, oropuche, mayaro, Plasmodium spp., or 
Bartonella bacilliformis, is well established [1-4]. 
Their correct diagnosis is necessary to enable 
administration of correct treatment. Nonetheless, in 
rural areas of low- and middle-income countries, 
correct diagnosis is a challenge, due to the presence of 
a series of common vague and undefined symptoms, 
especially in the early disease phases, and to the local 
diagnostic facilities. 
Bartonella bacilliformis is the etiological agent of 
Carrion’s disease, which is a neglected disease linked 
to people in low-socioeconomic populations in 
Andean valleys. This bacterium is transmitted by the 
bite of a sandfly, a member of the genus Lutzomyia. 
No reservoir other than humans has been identified 
[2]. This illness has two well-differentiated phases. 
The first is the acute so-called Oroya fever phase, 
characterized by fever and severe anemia (related to 
the fact that B. bacilliformis invade the red blood cells) 
in addition to a transitional immunosuppression [2]. 
Additionally, several symptoms and signs, including 
headache and jaundice, have also been described [1,5]. 
Regardless of its being considered the most lethal 
bacterial infection in the pre-antibiotic era, this illness 
may be successfully treated with a series of 
antimicrobial agents, including quinolones and 
macrolides, among others. However, it should be 
noted that the clinical cure has no direct correlation 
with microbiological eradication; asymptomatic 
carriers are frequent in endemic areas. The second 
phase of the disease, affecting semi-immune people, is 
characterized by the presence of endothelial 
proliferation resulting in warts (the so-called Peruvian 
warts) [2].  
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Since this illness mainly affects people in rural 
areas, one of the main problems is the lack of adequate 
technical and human resources for definitive 
diagnosis. Although some molecular diagnostic tools 
have been proposed [1,2,5], the diagnosis of Carrion’s 
disease in rural endemic areas is mostly restricted to 
clinical criteria or optical microscopy and it is 
frequently misdiagnosed by both [1,2].  
In this context, the presence of an active outbreak 
of Oroya fever was reported on March 2013 in 
Rodríguez de Mendoza, a rural area in the northeast of 
Peru [6]. Diagnosis was primarily based on the sudden 
presence of ill people, mostly with fever and chills, 
and was confirmed by positive microscopy results. 
This outbreak was of special concern because 
Carrion's disease had never been reported in this area, 
but had been reported in some endemic areas are 
relatively near the affected population; it has been 
reported that current climatic alterations underlie an 
expansion of this illness to new areas [2,7].  
The aim of this study was to characterize this 
outbreak using molecular techniques. 
 
Methodology 
Patients and sampling 
Fifty-three blood samples recovered in Rodríguez  
de Mendoza (Amazonas, Peru) were sent to the 
Instituto de Investigación Nutricional/Universidad 
Peruana de Ciencias Aplicadas to be included in the 
study. In all cases, patients were previously diagnosed 
with Carrion’s disease following clinical or 
microscopy criteria (Figure 1). Clinical and 
demographic data were recorded in a questionnaire. 
Additionally, domestic water samples and water-
well samples were also recovered and processed. 
 
Bacterial culture conditions 
Microorganisms were cultured as previously 
described [1]. Briefly, 2 mL of the blood samples were 
grown in Columbia agar medium supplemented with 
10% sheep blood and incubated at 28°C under 
anaerobic conditions. The plates were visually 
inspected at 24, 48, and 72 hours to detect 
contamination, and then every seven days for bacterial 
growth. 
 
DNA extraction 
The DNA was extracted from 200 µL of 
blood/water samples using a commercial extraction kit 
(High Pure Kit Preparation template, Roche Applied 
Science, Mannheim, Germany). Bacterial DNA 
obtained after extraction was diluted in 100 µL of 
nuclease-free water and then processed or stored at      
-20°C until use. 
 
PCR procedures 
Two different 16S rRNA PCR approaches were 
used: one using specific primers for Bartonella genus, 
and the other using universal primers. In both cases, 
primers and conditions have been previously described 
[1]. All the products obtained were recovered and 
sequenced (Macrogen, Seoul, Korea). 
 
Results 
A demographic analysis showed that 52.8% of the 
subjects included in the study were men and ranged in 
age from 4 months to 85 years; the subjects were 
mostly adults (60.4%), and 22 (41.5%) reported 
engaging in agrarian activities. Additionally, 11 
patients (20.7%) were not residents of the area, having 
reported a visit of less than one month in length 
(median, 2.4 days; range, 1-7 days) to the area. Nine 
(17%) patients, mostly outsiders (8/9) with a median 
stay in the area of 1.6 days (range, 1 to 3), reported 
engaging in aquatic activities, including in the river 
and thermal baths (Table 1).  
The review of the clinical data showed that the 
most frequent symptoms were headache and general 
discomfort (50.9%), followed by chills (32.1%) and 
fever (24.5%) (Table 2). Regarding treatment, 28 
(52.8%) were treated with ciprofloxacin, while 12 did 
not receive antibiotic treatment; the remaining 8 
patients were treated with amoxicillin plus clavulanic 
acid (4 patients), cotrimoxazole (2 patients), and 
sulfamethoxazole and metronidazole (1 patient each). 
Figure 1. Giemsa-stained red blood cells. Arrows mark red 
blood cells with internal bodies, which leads to 
misidentification. 
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  Table 1. Epidemiological characteristics 
 No. Frequency (%) 
Age   
< 5 years 5 9.4 % 
6–18 years 16 30.2 % 
> 18–55 years 24 45.3 % 
> 56 years 8 15.1 % 
   
Gender   
Male 28 52.8 % 
Female 25 47.2 % 
   
Ocupation
1
   
Farmer 22 41.5 % 
Housewife 6 11.3% 
Not indicated2 7 13.2 % 
   
Living in the area   
Resident3 28 52.8 % 
Non-resident 11 20.7 % 
No data 14 26.4 % 
   
Other   
Water activities 9 17 % 
1Only adults or minor developing economical activities; 2Four were not residents of the area; 3Patients reporting more than one month in the area 
 
 
 
 
Table 2. Clinical presentation 
Clinical presentation 
Number of cases 
n (%) 
Headache 
27 (50.9) 
General discomfort 
Chills 17 (32.1) 
Fever 13 (24.5) 
Joint pain 10 (18.9) 
Vomiting 9 (17) 
Abdominal pain 7 (13.2) 
Dizziness 5 (9.4) 
Myalgia 4  (7.5) 
Pallor 
3 (5.7) 
Cough 
Diarrhea 
Hyporexia 
Low back pain 2 (3.8) 
Epigastralgy 
1 (1.9) 
Jaundice 
Expectoration 
Itching 
Ecchymosis 
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All samples were analyzed by microscopy, 
microbiological and molecular techniques.  Despite 29 
(54.7%) cases being initially reported as positive by 
microscopy techniques, no amplified products were 
obtained with the 16S rRNA Bartonella-specific 
primers, showing that microscopy leads to a 
misidentification of Bartonella infections. Meanwhile, 
correct amplification of 1,503 bp was obtained in all 
the cases using the 16S rRNA universal primers. 
Twenty-six (49%) of these amplified products were 
randomly recovered and sequenced. Unexpectedly, the 
sequencing showed the presence of Sphingomonas 
faeni, suggesting that this microorganism was the 
causative microorganism of this outbreak. 
To determine the presence of B. bacilliformis, all 
samples were cultured under non-aerobic conditions. 
Bacterial growth was only detected in three samples. 
The DNA was extracted from the three growing 
microorganisms, and the different 16S rRNA PCR 
approaches were performed. Amplified product was 
obtained only with 16S rRNA universal primers. 
Analysis of the sequences showed the presence of 
Staphylococcus epidermidis, which was considered a 
contaminant. 
Domestic water samples and water-well samples 
were collected. DNA extraction followed by PCR 
amplification using the 16S rRNA universal primers 
was performed; the results showed the presence of 
different microorganisms, including previous 
uncultured aquatic microorganisms related to 
GenBank access numbers gb|GU758935.1 and 
GU758935.1 from water well, and HM238175 from 
both domestic and well samples, the last one 
belonging to a member of the Sphingomonas genus.  
 
Discussion 
The present report shows the presence of a 
misdiagnosed B. bacilliformis outbreak. The results 
showed the presence of S. faeni, an environmental 
microorganism that to the best of our knowledge, has 
never been described as a causative agent of an 
infectious outbreak. Although it cannot be ruled out, 
environmental PCR contamination was unlikely 
because PCR amplifications and DNA extractions 
were performed more than once, at different times, in 
two different settings. Moreover, negative controls 
were used, and no other Sphingomonas spp. was 
detected in any of the other laboratory samples 
analyzed prior, during, or after this study.  
In a previous report, the symptoms significantly 
associated with Oroya fever were chills, joint pain, 
cough, loss of appetite, pollakiuria and jaundice [1]. 
With the exception of chills, these symptoms were 
absent or had a minimal presence, being then non-
suggestive of Carrion’s disease. The fact that this 
outbreak was first associated with B. bacilliformis was 
probably due to the unexpected amount of cases, the 
proximity of endemic areas and, especially, due to the 
presence of positive blood thin smears (Figure 1). 
It has been shown that Sphingomonas spp. possess 
virulence factors showing a degree of identity with 
Brucella intracellular survival factors [8]. Moreover, 
Sphingomonas spp. possess the ability to penetrate 
within epithelial cells in vitro [9], and some reports 
have shown the presence of intracellular Gram-
negative microorganisms during Sphingomonas spp. 
infections [10]. However, to the best of our 
knowledge, no data about the ability of S. faeni or 
other Sphingomonas spp. to invade erythrocytes exists 
in the literature; the possible concomitant presence of 
other pathogens able to invade erythrocytes cannot be 
ruled out. A possibility is the presence of hemoplasma, 
which are wall-less erythrocytic bacteria unable to be 
cultured in vitro, classified within the genus 
Mycoplasma, which have been described in human 
and animal infections [11]. However, an in silico 
analysis showed that the 16S rRNA universal primers 
used were able to amplify a fragment of 1,433 bp of 
the 16S rRNA gene of hemoplasma species (i.e., 
Candidatus Mycoplasma haemominutum, GeneBank 
access NC_021007.1). Similarly, the primers used 
were also able to detect other well-known 
intraerythrocytic bacteria such as Anaplasma spp. 
Bacterial growth was only detected in three 
samples, but the growing microorganism was S. 
epidermidis, which was considered to be a sample 
contamination. These low positivity rates may have 
been found because the samples were directly plate-
cultured but no hemoculture was done, and because of 
the specific growth conditions cultured in order to 
detect the presence of B. bacilliformis [1]. 
Sphingomonas is a strictly aerobic microorganism 
commonly distributed both in hospitals and the natural 
environment in soil and water [12-14]. Several 
Sphingomonas spp. infections in humans have been 
reported, mostly limited to sporadic case reports or 
intra-hospital outbreaks, and mostly related to 
Sphingomonas paucimobilis [13,15]. To our 
knowledge, this is the first infectious Sphingomonas 
faeni outbreak described, and the first Sphingomonas 
spp. outbreak described in a non-hospital environment.  
Although S. faeni has low clinical virulence, it has 
a close relationship with S. paucimobilis, which is able 
to infect healthy non-compromised patients [16]. This 
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fact, together with the possible acquisition of virulence 
factors, as has been proposed for other member of the 
genus [8], may allow this microorganism to infect 
healthy people, causing an outbreak. Moreover, the 
specific socio-sanitary conditions of the area should be 
considered, including nutritional status, which may 
enhance the possibility of infections by low-virulence 
microorganisms [17]. In this sense, malnutrition and 
anemia among the infant population of the Amazonas 
region is about 32.8% and 56.7%, respectively [18]. 
Regarding the focus of infection, all probes 
seemed to be from the water. Sphingomonas is an 
environmental microorganism, and in this outbreak, 
almost 17% of the patients were reported to have 
engaged in aquatic activities; moreover, another 
Sphingomonas spp. (coincident with that recorded as 
GeneBank HM238175.1) was also detected in both 
domestic and well water sources.  
Unfortunately, we were not able to recover water 
from the thermal baths. Nevertheless, the 
environmental nature of S. faeni together with the 
presence of other Sphingomonas spp. in the potable 
water suggest an association between the water 
consumed and participation in aquatic activities with 
this outbreak. 
 
Conclusions 
Though sample contamination or the presence of a 
non-detect microorganisms cannot be ruled out, our 
findings strongly suggests the emergence of S. faeni as 
the causative agent of a community-acquired outbreak, 
probably associated with water. To our knowledge, 
this is the first report of a Sphingomonas spp. extra-
hospital outbreak, as well as the first description of S. 
faeni as a causative infectious agent. 
This outbreak was mistakenly attributed to B. 
bacilliformis, demonstrating that diagnosis of febrile 
syndromes by clinical criteria or microscopy may lead 
to misdiagnosis. Training of health personnel and the 
development of new diagnostic tools able to be 
implemented in endemic rural areas are urgently 
needed to overcome erroneous diagnoses and to avoid 
inappropriate treatments.  
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